Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
复制标题
DOI:
10.1186/ar4550
复制
发表时间:
2014-04-23
影响因子:
4.9
通讯作者:
Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan
中科院分区:
文献类型:
--
作者:
Sada KE;Yamamura M;Harigai M;Fujii T;Dobashi H;Takasaki Y;Ito S;Yamada H;Wada T;Hirahashi J;Arimura Y;Makino H;Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan
We investigated the clinical and serological features of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in Japan using data from a nationwide, prospective, inception cohort study. In total, 156 Japanese patients with newly diagnosed AAV were classified according to the European Medicines Agency (EMEA) algorithm with exploratory surrogate markers for AAV-related non-granulomatous pulmonary lesions, predefined as alveolar haemorrhage and interstitial lung disease (ILD), and their clinical and serological features were evaluated. Using the EMEA algorithm, we identified 14 patients (9.0%) with eosinophilic granulomatosis with polyangiitis (EGPA), 33 (21.2%) with granulomatosis with polyangiitis (GPA), 78 (50.0%) with microscopic polyangiitis and renal-limited vasculitis (MPA/RLV), and 31 (19.9%) with unclassifiable vasculitis. The average ages of patients with EGPA (male/female, 5/9), GPA (12/21), and MPA/RLV (35/43) and unclassifiable (9/22) were 58.0, 63.6, 71.1, and 70.6 years, respectively. Myeloperoxidase (MPO)-ANCA and proteinase-3 ANCA positivity was 50.0% and 0% for EGPA, 54.6% and 45.5% for GPA, 97.4% and 2.6% for MPA/RLV, and 93.5% and 3.2% for unclassifiable, respectively. According to the Birmingham Vasculitis Activity Score (BVAS), cutaneous (71.4%) and nervous system (92.9%) manifestations were prominent in EGPA and ear, nose, and throat manifestations (84.9%) and chest manifestations (66.7%) in GPA. Renal manifestations developed frequently in MPA/RLV (91.0%) and GPA (63.6%). The average serum creatinine levels were 0.71 mg/dL for EGPA, 1.51 mg/dL for GPA, 2.46 mg/dL for MPA/RLV, and 0.69 mg/dL for unclassifiable. The percentages of patients with ILD were 14.3% for EGPA, 9.0% for GPA, 47.4% for MPA/RLV, and 61.3% for unclassifiable. Patients with ILD (n = 61) had significantly lower BVAS (P = 0.019) with fewer ear, nose, and throat and cardiovascular manifestations than patients without ILD (n = 95). MPO-ANCA-positive MPA/RLV is the most common form of AAV in Japanese patients, and one-half of patients with GPA were positive for MPO-ANCA. ILD is an important clinical manifestation in Japanese patients with AAV. Unclassifiable vasculitis with MPO-ANCA positivity and ILD may represent a novel variant of MPA. The University Hospital Medical Information Network Clinical Trials Registry: UMIN000001648. Registered 28 February 2009.
登录
查看更多内容
DOI:
10.1093/ndtplus/sfq050
发表时间:
2010-08
期刊:
NDT plus
影响因子:
--
作者:
Bhanji A;Karim M
通讯作者:
Karim M
影响因子:
19.6
作者:
Hauer, HA;Bajema, IM;Hagen, EC
通讯作者:
Hagen, EC
影响因子:
4.3
作者:
Foulon, Guillaume;Delaval, Philippe;Crestani, Bruno
通讯作者:
Crestani, Bruno
影响因子:
4.3
作者:
Ando, Masaru;Miyazaki, Eishi;Kumamoto, Toshihide
通讯作者:
Kumamoto, Toshihide
影响因子:
6.9
作者:
Homma, S;Matsushita, H;Nakata, K
通讯作者:
Nakata, K